查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386204

兒童用疫苗市場報告：2030 年趨勢、預測與競爭分析

Pediatric Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

兒童用疫苗趨勢和預測

預計到 2030 年，全球兒童用疫苗市場將達到 308 億美元，2024 年至 2030 年複合年成長率為 5.7%。該市場的主要驅動力是家長和醫療保健相關人員對這些疫苗益處的認知不斷提高、對組合疫苗的需求不斷成長以及新型創新兒童用疫苗的出現。這是一個持續發展的過程。全球兒童用疫苗市場的未來充滿希望，在感染疾病、癌症、過敏、肺炎球菌疾病以及流感、麻疹、腮腺炎和德國德國麻疹（MMR）應用方面存在機會。

兒童用疫苗市場洞察

Lucintel 預測，由於大量使用結合形式來抑制這些病毒，肺炎球菌和腦膜炎球菌疾病將在預測期內出現最高成長。

由於擁有強大的醫療基礎設施、政府在免疫計劃方面的積極配合措施以及不斷成長的兒童人口，預計北美在預測期內將出現最高的成長。

市場規模/估計：以金額計算的兒童用疫苗市場規模估計（十億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔分析：依疫苗類型、技術、應用和地區分類的兒童用疫苗市場規模（金額（$B））。

區域分析：北美、歐洲、亞太地區和世界其他地區的兒童用疫苗市場區隔。

成長機會：依類型、技術、應用和地區分析兒童用疫苗的成長機會。

策略分析：兒童用疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球兒童用疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球兒童用疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依疫苗類型分類的全球兒童用疫苗市場
    • 單價
    • 多效價的
  • 依技術分類的全球兒童用疫苗市場
    • 減弱毒性
    • 失活
    • 次單元
    • 類毒素
    • 共軛
    • 其他
  • 全球兒童用疫苗市場（依應用）
    • 感染疾病
    • 癌症
    • 過敏
    • 肺炎球菌疾病
    • 流感
    • 麻疹、腮腺炎、德國麻疹(MMR)
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球兒童用疫苗市場區域分佈
  • 北美兒童用疫苗市場
  • 歐洲兒童用疫苗市場
  • 亞太地區兒童用疫苗市場
  • 其他地區兒童用疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依疫苗類型分類的全球兒童用疫苗市場成長機會
    • 全球兒童用疫苗市場成長機會（依技術）
    • 全球兒童用疫苗市場成長機會（依應用）
    • 全球兒童用疫苗市場成長機會（依地區）
  • 全球兒童用疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球兒童用疫苗市場產能擴張
    • 全球兒童用疫苗市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • GlaxoSmithKline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute of India
簡介目錄

Pediatric Vaccine Trends and Forecast

The future of the global pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications. The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

A more than 150-page report is developed to help in your business decisions.

Pediatric Vaccine by Segment

The study includes a forecast for the global pediatric vaccine by vaccine type, technology, application, and region.

Pediatric Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent
  • Multivalent

Pediatric Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Conjugate
  • Others

Pediatric Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Infectious Disease
  • Cancer
  • Allergy
  • Pneumococcal Disease
  • Influenza
  • Measles, Mumps, and Rubella (Mmr)
  • Others

Pediatric Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pediatric Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pediatric vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pediatric vaccine companies profiled in this report include-

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute Of India

Pediatric Vaccine Market Insights

Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Features of the Global Pediatric Vaccine Market

Market Size Estimates: Pediatric vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pediatric vaccine market size by vaccine type, technology, application, and region in terms of value ($B).

Regional Analysis: Pediatric vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, applications, and regions for the pediatric vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pediatric vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pediatric vaccine market size?

Answer: The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030.

Q.2 What is the growth forecast for pediatric vaccine market?

Answer: The global pediatric vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pediatric vaccine market?

Answer: The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

Q4. What are the major segments for pediatric vaccine market?

Answer: The future of the pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications.

Q5. Who are the key pediatric vaccine market companies?

Answer: Some of the key pediatric vaccine companies are as follows:

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute Of India

Q6. Which pediatric vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

Q7. In pediatric vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pediatric vaccine market by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pediatric Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pediatric Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pediatric Vaccine Market by Vaccine Type
    • 3.3.1: Monovalent
    • 3.3.2: Multivalent
  • 3.4: Global Pediatric Vaccine Market by Technology
    • 3.4.1: Live Attenuated
    • 3.4.2: Inactivated
    • 3.4.3: Subunit
    • 3.4.4: Toxoid
    • 3.4.5: Conjugate
    • 3.4.6: Others
  • 3.5: Global Pediatric Vaccine Market by Application
    • 3.5.1: Infectious Disease
    • 3.5.2: Cancer
    • 3.5.3: Allergy
    • 3.5.4: Pneumococcal Disease
    • 3.5.5: Influenza
    • 3.5.6: Measles, Mumps, and Rubella (MMR)
    • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pediatric Vaccine Market by Region
  • 4.2: North American Pediatric Vaccine Market
    • 4.2.1: North American Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.2.2: North American Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.3: European Pediatric Vaccine Market
    • 4.3.1: European Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.3.2: European Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.4: APAC Pediatric Vaccine Market
    • 4.4.1: APAC Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.4.2: APAC Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.5: ROW Pediatric Vaccine Market
    • 4.5.1: ROW Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.5.2: ROW Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pediatric Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Pediatric Vaccine Market by Technology
    • 6.1.3: Growth Opportunities for the Global Pediatric Vaccine Market by Application
    • 6.1.4: Growth Opportunities for the Global Pediatric Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Pediatric Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pediatric Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pediatric Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Merck & Co
  • 7.3: Sanofi
  • 7.4: Pfizer
  • 7.5: Johnson & Johnson
  • 7.6: Bharat Biotech International
  • 7.7: Serum Institute of India